HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PBA Announces New Leadership; Honest Company Names CFO; Beauty Executive News

Executive Summary

Nina Daily, chief marketing officer at the Professional Beauty Association since July 2018, will succeed Steve Sleeper as executive director at the end of June when Sleeper retires. More cosmetics industry appointments.

You may also be interested in...



Professional Beauty Association Issues Guidelines As Salons Begin Reopening Across US; News In Brief

Ulta Beauty, Inc. is reopening 180 stores in selected states, a number of which will offer hair services with heightened safety protocols. Meanwhile, the Professional Beauty Association has issued guidelines to help salons reopen safely in the third of US states that are allowing them to do so. Those states do not yet include California, for reasons explained by Governor Gavin Newsom on 7 May.

Coty ‘Absolutely Not In Fire Sale Mode’ Following Younique Divestiture That ‘Stunned’ Investors

Leadership assured analysts on 6 November that Coty's Professional Beauty and Brazilian businesses are strong performers of high interest to potential acquirers, unlike Younique. Coty recently sold its majority stake in the social selling company back to its founders at a price that raised eyebrows.

Entries Begin To Roll In For 2024 Industry Awards

Entries have now begun rolling in for the Global Generics & Biosimilars Awards, which returns to Milan this October, Free to enter and attend, the ceremony recognizes the top achievements across the generics, biosimilars and value added medicines industries.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS150937

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel